Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular and cellular neurosciences

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mcn.2010.06.017PMID 20603216PMCID PMC2945816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson’s disease

  2010cited by this paper
• Efficient derivation of functional floor plate tissue from human embryonic stem cells.

  2010influential reference
• Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum

  2009cited by this paper
• Organization of the human embryonic ventral mesencephalon.

  2009cited by this paper
• Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells

  2009influential reference
• Human Embryonic Stem Cell Differentiation Toward Regional Specific Neural Precursors

  2009cited by this paper
• Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis

  2009cited by this paper
• The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal.

  2009cited by this paper
• Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools

  2009cited by this paper
• Molecular and Cellular Neuroscience

  2009cited by this paper
• The Role of Lmx1a in the Differentiation of Human Embryonic Stem Cells into Midbrain Dopamine Neurons in Culture and After Transplantation into a Parkinson's Disease Model

  2009influential reference
• Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development.

  2009cited by this paper
• CD15, CD24, and CD29 Define a Surface Biomarker Code for Neural Lineage Differentiation of Stem Cells

  2009cited by this paper
• Differentiation of spinal motor neurons from pluripotent human stem cells

  2009cited by this paper
• Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

  2009influential reference
• Noggin Enhances Dopamine Neuron Production from Human Embryonic Stem Cells and Improves Behavioral Outcome After Transplantation into Parkinsonian Rats

  2008cited by this paper
• Developmental neuroscience: Hox and Fox

  2008cited by this paper
• Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in Parkinsonian rats

  2008cited by this paper
• An intrinsic mechanism of corticogenesis from embryonic stem cells

  2008cited by this paper
• The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.

  2008cited by this paper
• Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells

  2008cited by this paper
• Retinoic acid in the development, regeneration and maintenance of the nervous system

  2007cited by this paper
• Enhanced Yield of Neuroepithelial Precursors and Midbrain‐Like Dopaminergic Neurons from Human Embryonic Stem Cells Using the Bone Morphogenic Protein Antagonist Noggin

  2007influential reference
• The foxa2 Gene Controls the Birth and Spontaneous Degeneration of Dopamine Neurons in Old Age

  2007cited by this paper
• Markers and Methods for Cell Sorting of Human Embryonic Stem Cell‐Derived Neural Cell Populations

  2007cited by this paper
• Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner

  2007cited by this paper
• Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes

  2006cited by this paper
• Transcriptional control of midbrain dopaminergic neuron development

  2006cited by this paper
• An Early Role for Wnt Signaling in Specifying Neural Patterns of Cdx and Hox Gene Expression and Motor Neuron Subtype Identity

  2006cited by this paper
• Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.

  2006cited by this paper
• Toward xeno-free culture of human embryonic stem cells.

  2006cited by this paper
• ES cell-derived neuroepithelial cell cultures.

  2006cited by this paper
• Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

  2005influential reference
• Projections of diencephalic dopamine neurons into the spinal cord in mice

  2005cited by this paper
• Context-dependent neuronal differentiation and germ layer induction of Smad4-/- and Cripto-/- embryonic stem cells.

  2005cited by this paper
• Ontogeny of tyrosine hydroxylase mRNA expression in mid‐ and forebrain: Neuromeric pattern and novel positive regions

  2005cited by this paper
• Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

  2005influential reference
• Derivation of midbrain dopamine neurons from human embryonic stem cells.

  2004influential reference
• Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells.

  2004cited by this paper
• Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells

  2003cited by this paper
• Progressive induction of caudal neural character by graded Wnt signaling

  2002cited by this paper
• Ih Channels Contribute to the Different Functional Properties of Identified Dopaminergic Subpopulations in the Midbrain

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Differential Expression of the Small-Conductance, Calcium-Activated Potassium Channel SK3 Is Critical for Pacemaker Control in Dopaminergic Midbrain Neurons

  2001cited by this paper
• Pax6 regulates the identity of embryonic diencephalic neurons.

  2001influential reference
• Enhanced potency of human Sonic hedgehog by hydrophobic modification.

  2001influential reference
• Convergent inductive signals specify midbrain, hindbrain, and spinal cord identity in gastrula stage chick embryos.

  1999cited by this paper
• FGF8 can activate Gbx2 and transform regions of the rostral mouse brain into a hindbrain fate.

  1999cited by this paper
• The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

  1999cited by this paper
• Evidence that FGF8 signalling from the midbrain-hindbrain junction regulates growth and polarity in the developing midbrain.

  1997cited by this paper
• A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro.

  1997influential reference
• Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans

  1996cited by this paper
• Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function

  1996influential reference
• Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis.

  1995influential reference
• Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a

  1992cited by this paper
• Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization

  1989cited by this paper
• Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

  1988cited by this paper

• Differentiation of human iPSCs into dopaminergic neurons: comparative analysis of 2D and 3D protocols for disease modeling and pharmacology.

  2026cites this paper
• Investigating the efficacy, methods, and challenges of induced pluripotent stem cells (iPSC) therapy in Parkinson's disease

  2026cites this paper
• Protocol for the generation and xenotransplantation of human induced pluripotent stem cell-derived neural progenitor cells into the mouse forebrain

  2026cites this paper
• Human Induced Pluripotent Stem Cells: Directed Differentiation Methods and Applications in Brain Diseases

  2025cites this paper
• Investigating the ageing-Parkinson’s disease nexus: standardisation of in vitro models and techniques by the PD-AGE network

  2025cites this paper
• Progression of differentiation of iPSCs into specific subtypes of neurons.

  2025cites this paper
• Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: Insights from non-human primate studies

  2025cites this paper
• Mesenchymal stem cell therapy for Alzheimer's disease: A novel therapeutic approach for neurodegenerative diseases.

  2024cites this paper
• The Neuroanatomy of Induced Pluripotent Stem Cells: In Vitro Models of Subcortical Nuclei in Neurodegenerative Disorders

  2024cites this paper
• Human stem cell transplantation models of Alzheimer’s disease

  2024cites this paper
• Induced pluripotent stem cell–related approaches to generate dopaminergic neurons for Parkinson’s disease

  2024cites this paper
• Autologous vs heterologous cell replacement strategies for Parkinson disease and other neurologic diseases.

  2024cites this paper
• Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases

  2024cites this paper
• Impaired Sonic Hedgehog Responsiveness of Induced Pluripotent Stem Cell-Derived Floor Plate Cells Carrying the LRRK2-I1371V Mutation Contributes to the Ontogenic Origin of Lower Dopaminergic Neuron Yield

  2024cites this paper
• miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease

  2023cites this paper
• MiR-210-5p promotes the differentiation of human induced pluripotent stem cells into dopaminergic neural precursors by targeting SMAD4 and SUFU and treats parkinsonian rats.

  2023cites this paper
• Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making

  2023cites this paper
• The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia

  2023cites this paper
• A Modified Differentiation Protocol In Vitro to Generate Dopaminergic Neurons from Pluripotent Stem Cells

  2023cites this paper
• Retinoic acid signaling in development and differentiation commitment and its regulatory topology.

  2023cites this paper
• The role of Smo-Shh/Gli signaling activation in the prevention of neurological and ageing disorders

  2023cites this paper
• LUHMES Cells: Phenotype Refinement and Development of an MPP+-Based Test System for Screening Antiparkinsonian Drugs

  2023cites this paper
• Photobiomodulation Therapy and Cell Therapy Improved Parkinson's Diseases by Neuro-regeneration and Tremor Inhibition.

  2022cites this paper
• Post-transcriptional and Post-translational Modifications of Primary Cilia: How to Fine Tune Your Neuronal Antenna

  2022cites this paper
• Electrophysiological Properties of Induced Pluripotent Stem Cell-Derived Midbrain Dopaminergic Neurons Correlate With Expression of Tyrosine Hydroxylase

  2022cites this paper
• Mitochondrial dysfunction of induced pluripotent stem cells-based neurodegenerative disease modeling and therapeutic strategy

  2022cites this paper
• Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery

  2022cites this paper
• Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson's disease.

  2021cites this paper
• Single-Cell Profiling of Coding and Noncoding Genes in Human Dopamine Neuron Differentiation

  2021cites this paper
• Autologous Induced Pluripotent Stem Cell–Based Cell Therapies: Promise, Progress, and Challenges

  2021cites this paper
• Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson’s Disease Drug Development

  2021cites this paper
• Therapeutic Applications of Induced Pluripotent Stem Cell Use in Parkinson’s Disease Models

  2021cites this paper
• On the Road from Phenotypic Plasticity to Stem Cell Therapy

  2021cites this paper
• The Different Molecular Code in Generation of Dopaminergic Neurons from Astrocytes and Mesenchymal Stem Cells

  2021cites this paper
• Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s disease

  2020cites this paper
• Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease Patients

  2020cites this paper
• Dopaminergic Neuron-Related Stem Cells

  2020cites this paper
• Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside

  2020cites this paper
• Building a Human Brain for Research

  2020cites this paper
• Cell transplantation therapy for Parkinson's disease

  2020cites this paper
• Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials

  2020cites this paper
• Recent progress in translational engineered in vitro models of the central nervous system

  2020cites this paper
• Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinsonâ€TMs disease

  2020cites this paper
• Stem cell therapy for Alzheimer's disease

  2020cites this paper
• Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances, and Limitations.

  2020cites this paper
• PCL/gelatin scaffolds and BETA-BOSWELLIC ACID (BBA) synergistically increase the efficiency of CGR8 stem cells differentiation into dopaminergic neuron: A new paradigm of Parkinson's disease cell therapy.

  2020cites this paper
• The iNs and Outs of Direct Reprogramming to Induced Neurons

  2020cites this paper
• Direct conversion of human fibroblasts into dopaminergic neuron-like cells using small molecules and protein factors

  2020cites this paper
• Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective

  2020cites this paper
• Recent advances ofinduced pluripotent stem cells application in neurodegenerative diseases.

  2019cites this paper
• One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological Disorders

  2019cites this paper
• Alzheimer’s in a dish – induced pluripotent stem cell-based disease modeling

  2019cites this paper
• Modeling neuronopathic storage diseases with patient-derived culture systems.

  2019cites this paper
• CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons

  2019cites this paper
• Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.

  2019cites this paper
• Generation of human midbrain organoids from induced pluripotent stem cells

  2019cites this paper
• Single Cell Gene Expression Analysis Reveals Human Stem Cell-Derived Graft Composition in a Cell Therapy Model of Parkinson’s Disease

  2019cites this paper
• Using induced pluripotent stem cells for modeling Parkinson’s disease

  2019cites this paper
• Stem Cell Therapy: A Great Leap Forward in Alzheimer’s Treatment

  2019cites this paper
• Differentiation of Mesenchymal Stem Cells to Neuroglia: in the Context of Cell Signalling

  2019cites this paper
• Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD

  2019cites this paper
• High ‐ throughput identificationof factorspromotingneuronal differentiation of human neural progenitor cells inmicroscale 3 D cell culture

  2019cites this paper
• Towards stem cell based therapies for Parkinson's disease

  2018cites this paper
• 2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling

  2018cites this paper
• Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation

  2018cites this paper
• Modelling neurodegenerative diseases in vitro : Recent advances in 3D iPSC technologies

  2018cites this paper
• Regulation of Neural Stem Cell Fate by Natural Products

  2018cites this paper
• Chapter 15 Stem Cell Therapy for Parkinson ' s Disease

  2018cites this paper
• Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.

  2018cites this paper
• Treating Neurodegenerative Disorders: Towards Detailed Pathophysiology and Precision Medicine

  2018cites this paper
• Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease

  2018cites this paper
• In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells

  2018cites this paper
• Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease

  2018cites this paper
• High‐throughput identification of factors promoting neuronal differentiation of human neural progenitor cells in microscale 3D cell culture

  2018cites this paper
• Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis

  2018cites this paper
• Cell reprogramming approaches in gene- and cell-based therapies for Parkinson's disease.

  2018cites this paper
• Generation of dopamine neuronal-like cells from induced neural precursors derived from adult human cells by non-viral expression of lineage factors

  2018cites this paper
• Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

  2018cites this paper
• Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism

  2018cites this paper
• Potentiel thérapeutique de neurones dopaminergiques dérivés de cellules souches embryonnaires de souris dans un modèle murin de la maladie de Parkinson

  2017cites this paper
• Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.

  2017cites this paper
• Understanding Parkinson’s Disease through the Use of Cell Reprogramming

  2017cites this paper
• 6 Huntington’s Disease and Stem Cells

  2017cites this paper
• A Knockin Reporter Allows Purification and Characterization of mDA Neurons from Heterogeneous Populations.

  2017cites this paper
• Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma

  2017influential citation
• New Insights Into the Roles of Retinoic Acid Signaling in Nervous System Development and the Establishment of Neurotransmitter Systems.

  2017cites this paper
• A novel method to differentiate rat embryonic stem cells into dopaminergic neurons in vitro

  2017cites this paper
• Seq-ing Markers of Midbrain Dopamine Neurons.

  2017cites this paper
• Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives

  2017cites this paper
• The role of nonhuman primate models in the development of cell-based therapies for Parkinson’s disease

  2017cites this paper
• Human polymorphisms in nicotinic receptors: a functional analysis in iPS‐derived dopaminergic neurons

  2017cites this paper
• Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation

  2017cites this paper
• Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential

  2017cites this paper
• Distinct retinoic acid receptor (RAR) isotypes control differentiation of embryonal carcinoma cells to dopaminergic or striatopallidal medium spiny neurons

  2017cites this paper
• Mimicking Parkinson’s Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models

  2017cites this paper
• Assessment of a potential therapeutic target in the Hedgehog pathway for the eradication of primitive chronic myeloid leukemia cells

  2017cites this paper
• Generation of Dopamine-Secreting Cells from Human Adipose Tissue-Derived Stem Cells In Vitro

  2017cites this paper
• Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons

  2017influential citation
• Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease

  2017cites this paper
• Utilization of stem cells to model Parkinson's disease – current state and future challenges

  2016cites this paper